Prostaglandin synthase 2 - PubMed (original) (raw)

Review

Prostaglandin synthase 2

H R Herschman. Biochim Biophys Acta. 1996.

No abstract available

PubMed Disclaimer

Similar articles

• Eicosanoids and iso-eicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease.
  Maclouf J, Folco G, Patrono C. Maclouf J, et al. Thromb Haemost. 1998 Apr;79(4):691-705. Thromb Haemost. 1998. PMID: 9569176 Review. No abstract available.
• The heterologous expression and characterization of human prostaglandin G/H synthase-2 (COX-2).
  Miller DB, Munster D, Wasvary JS, Simke JP, Peppard JV, Bowen BR, Marshall PJ. Miller DB, et al. Biochem Biophys Res Commun. 1994 May 30;201(1):356-62. doi: 10.1006/bbrc.1994.1709. Biochem Biophys Res Commun. 1994. PMID: 8198595
• Bases for a spinal analgesic action of cyclooxygenase inhibitors.
  Vanegas H. Vanegas H. Proc West Pharmacol Soc. 2002;45:225-7. Proc West Pharmacol Soc. 2002. PMID: 12434585 Review. No abstract available.
• Formation of cyclooxygenase-derived eicosanoids by a parasitic intravascular nematode.
  Liu LX, Serhan CN, Weller PF. Liu LX, et al. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:509-12. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825371 No abstract available.
• Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
  Penglis PS, Cleland LG, Demasi M, Caughey GE, James MJ. Penglis PS, et al. J Immunol. 2000 Aug 1;165(3):1605-11. doi: 10.4049/jimmunol.165.3.1605. J Immunol. 2000. PMID: 10903770

Cited by

• Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.
  Wang YH, Lin CW, Huang CW. Wang YH, et al. Biomedicines. 2024 Sep 12;12(9):2085. doi: 10.3390/biomedicines12092085. Biomedicines. 2024. PMID: 39335598 Free PMC article. Review.
• Synthesis and elucidation of strained galactopyronose esters as selective cyclooxygenase-2 inhibitor: a comprehensive computational approach.
  Musa MS, Miah MS, Munni YA, Patwary MAM, Kazi M, Matin MM. Musa MS, et al. RSC Adv. 2024 Sep 24;14(41):30469-30481. doi: 10.1039/d4ra03520h. eCollection 2024 Sep 18. RSC Adv. 2024. PMID: 39318455 Free PMC article.
• Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?
  Broos JY, van der Burgt RTM, Konings J, Rijnsburger M, Werz O, de Vries HE, Giera M, Kooij G. Broos JY, et al. J Neuroinflammation. 2024 Jan 17;21(1):21. doi: 10.1186/s12974-023-02981-w. J Neuroinflammation. 2024. PMID: 38233951 Free PMC article. Review.
• Himalayan flora: targeting various molecular pathways in lung cancer.
  James A, Akash K, Sharma A, Bhattacharyya S, Sriamornsak P, Nagraik R, Kumar D. James A, et al. Med Oncol. 2023 Oct 3;40(11):314. doi: 10.1007/s12032-023-02171-x. Med Oncol. 2023. PMID: 37787816 Review.
• PGE2 Produced by Exogenous MSCs Promotes Immunoregulation in ARDS Induced by Highly Pathogenic Influenza A through Activation of the Wnt-β-Catenin Signaling Pathway.
  Yudhawati R, Shimizu K. Yudhawati R, et al. Int J Mol Sci. 2023 Apr 14;24(8):7299. doi: 10.3390/ijms24087299. Int J Mol Sci. 2023. PMID: 37108459 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)